Single-cell RNA-sequencing combined with bulk RNA-sequencing analysis of peripheral blood reveals the characteristics and key immune cell genes of ulcerative colitis
暂无分享,去创建一个
Lie Zheng | Dan Qiao | Tiegang Xiao | Yan-cheng Dai | R. Que | Yali Zhang | Chen-Ye Fang | Qiu-Qin Chen | Li-juan Wang | D. Qiao
[1] C. Lamb,et al. The future of precision medicine to predict outcomes and control tissue remodeling in inflammatory bowel disease. , 2021, Gastroenterology.
[2] A. Hart,et al. How should pain, fatigue and emotional wellness be incorporated into treatment goals for optimal management of IBD? , 2021, Gastroenterology.
[3] C. Le Berre,et al. Evolving short- and long-term goals of management of IBD: getting it right, making it last , 2022, Gastroenterology.
[4] M. Parkes,et al. How do we predict a patient's disease course and whether they will respond to specific treatments? , 2021, Gastroenterology.
[5] S. Danese,et al. Breaking through the therapeutic ceiling: what will it take? , 2021, Gastroenterology.
[6] Xinying Wang,et al. Treatment Decision-making in Chinese Inflammatory Bowel Disease Patients. , 2021, Inflammatory bowel diseases.
[7] A. Zaraisky,et al. Cytoskeletal protein Zyxin in embryonic development: from controlling cell movements and pluripotency to regulating embryonic patterning , 2021, The FEBS journal.
[8] L. Peyrin-Biroulet,et al. Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. , 2021, The lancet. Gastroenterology & hepatology.
[9] Y. Hiasa,et al. Association Between Peripheral Blood Monocyte Count and Mucosal Healing in Japanese Patients With Ulcerative Colitis , 2021, Clinical and translational gastroenterology.
[10] Zhi-Peng Tang,et al. Regulation of Endoplasmic Reticulum Stress-Autophagy: A Potential Therapeutic Target for Ulcerative Colitis , 2021, Frontiers in Pharmacology.
[11] A. Gryglewski,et al. Changes in γδT Cells in Peripheral Blood of Patients with Ulcerative Colitis Exacerbations , 2021, Archivum immunologiae et therapiae experimentalis.
[12] B. Cillero-Pastor,et al. Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice , 2021, Frontiers in Immunology.
[13] P. Hegyi,et al. Granulocyte and monocyte apheresis as an adjunctive therapy to induce and maintain clinical remission in ulcerative colitis: a systematic review and meta-analysis , 2021, BMJ Open.
[14] Qijin Yin,et al. Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction , 2021, BMC Medical Genomics.
[15] Cheng-Jian Xu,et al. Identification of Novel Population-Specific Cell Subsets in Chinese Ulcerative Colitis Patients Using Single-Cell RNA Sequencing , 2021, Cellular and molecular gastroenterology and hepatology.
[16] Judy H. Cho,et al. Inflamed ulcerative colitis regions associated to MRGPRX2-mediated mast cell degranulation and cell activation modules, defining a new therapeutic target. , 2021, Gastroenterology.
[17] E. Mukamel,et al. Single-Cell Sequencing of Brain Cell Transcriptomes and Epigenomes , 2021, Neuron.
[18] P. Loke,et al. Single Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients. , 2020, Gastroenterology.
[19] D. Tian,et al. Comprehensive analysis of key biomarkers, immune infiltration and potential therapeutic agents for ulcerative colitis. , 2020, Life sciences.
[20] M. Sarfati,et al. Single-Cell Protein and RNA Expression Analysis of Mononuclear Phagocytes in Intestinal Mucosa and Mesenteric Lymph Nodes of Ulcerative Colitis and Crohn’s Disease Patients , 2020, Cells.
[21] F. Jamali,et al. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[22] F. Kondo,et al. Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone , 2020, Inflammatory Intestinal Diseases.
[23] L. Peyrin-Biroulet,et al. Evolving therapeutic goals in ulcerative colitis: towards disease clearance , 2019, Nature Reviews Gastroenterology & Hepatology.
[24] Aviv Regev,et al. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis , 2019, Cell.
[25] H. Ebada,et al. Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity , 2019, Autoimmunity Highlights.
[26] Ashwin N. Ananthakrishnan,et al. ACG Clinical Guideline: Ulcerative Colitis in Adults , 2019, The American journal of gastroenterology.
[27] G. Genovese,et al. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease , 2018, Journal of Crohn's & colitis.
[28] Y-X Wang,et al. Zyxin: a mechanotransductor to regulate gene expression. , 2019, European review for medical and pharmacological sciences.
[29] A. Cambi,et al. Super-Resolution Correlative Light and Electron Microscopy (SR-CLEM) Reveals Novel Ultrastructural Insights Into Dendritic Cell Podosomes , 2018, Front. Immunol..
[30] S. Lele,et al. Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation , 2018, Proceedings of the National Academy of Sciences.
[31] X. Suárez-Calvet,et al. Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis Patients. , 2018, Inflammatory bowel diseases.
[32] P. Lepage,et al. TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice , 2018, Journal of Crohn's & colitis.
[33] V. V. van Hinsbergh,et al. RhoA, RhoB and RhoC differentially regulate endothelial barrier function , 2017, Small GTPases.
[34] Shuyuan Liu,et al. RhoB induces the production of proinflammatory cytokines in TLR‐triggered macrophages , 2017, Molecular immunology.
[35] C. Langner,et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.
[36] S. Brierley,et al. Acute colitis chronically alters immune infiltration mechanisms and sensory neuro-immune interactions , 2017, Brain, Behavior, and Immunity.
[37] G. Thomas,et al. Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis , 2016, Oncoimmunology.
[38] M. Zimmerman,et al. Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity , 2015, Inflammatory bowel diseases.
[39] A. Hart,et al. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview , 2015, The American Journal of Gastroenterology.
[40] Bo Li,et al. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[41] Yongzhi Yang,et al. Overexpression of miR-21 in patients with ulcerative colitis impairs intestinal epithelial barrier function through targeting the Rho GTPase RhoB. , 2013, Biochemical and biophysical research communications.
[42] G. Rogler,et al. Sphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitis , 2010, Gut.
[43] G. Prendergast,et al. Loss of RhoB Expression Enhances the Myelodysplastic Phenotype of Mammalian Diaphanous-Related Formin mDia1 Knockout Mice , 2009, PloS one.
[44] J. Schwab,et al. Lesional expression of RhoA and RhoB following traumatic brain injury in humans. , 2004, Journal of neurotrauma.
[45] G. Rogler,et al. Cathepsin D is up‐regulated in inflammatory bowel disease macrophages , 2004, Clinical and experimental immunology.